Parathyroid carcinoma is increasingly linked to defects in the CDC73 gene and alterations in the tumor suppressor protein parafibromin, underscoring the importance of molecular insights in disease management [11,12]. Here, CDC73 is linked to parathyroid gland carcinoma.